Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Nira Bloom"'
Autor:
Olga Ostrovsky, Katia Beider, Yan Morgulis, Nira Bloom, Angel Cid-Arregui, Avichai Shimoni, Israel Vlodavsky, Arnon Nagler
Publikováno v:
Cells, Vol 10, Iss 12, p 3489 (2021)
Heparanase is an endo-β-glucuronidase that is best known for its pro-cancerous effects but is also implicated in the pathogenesis of various viruses. Activation of heparanase is a common strategy to increase viral spread and trigger the subsequent i
Externí odkaz:
https://doaj.org/article/a14e451496104742984e45ee76b62551
Autor:
Olga Ostrovsky, Polina Baryakh, Yan Morgulis, Margarita Mayorov, Nira Bloom, Katia Beider, Avichai Shimoni, Israel Vlodavsky, Arnon Nagler
Publikováno v:
Cells, Vol 10, Iss 10, p 2523 (2021)
The HPSE gene encodes heparanase (HPSE), a key player in cancer, inflammation, and autoimmunity. We have previously identified a strong HPSE gene enhancer involved in self-regulation of heparanase by negative feedback exerted in a functional rs469360
Externí odkaz:
https://doaj.org/article/62328108394d4e648beef44b2a0652d4
Autor:
Avichai Shimoni, Polina Baryakh, Israel Vlodavsky, Yan Morgulis, Nira Bloom, Margarita Mayorov, Arnon Nagler, Olga Ostrovsky, Katia Beider
Publikováno v:
Cells; Volume 10; Issue 10; Pages: 2523
Cells
Cells, Vol 10, Iss 2523, p 2523 (2021)
Cells
Cells, Vol 10, Iss 2523, p 2523 (2021)
The HPSE gene encodes heparanase (HPSE), a key player in cancer, inflammation, and autoimmunity. We have previously identified a strong HPSE gene enhancer involved in self-regulation of heparanase by negative feedback exerted in a functional rs469360
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a734c955dc3fdd9eab7280c489bfa097
Autor:
Avichai Shimoni, Noga Shem-Tov, Ivetta Danylesko, Nira Bloom-Varda, Rina Sareli, Ronit Yerushalmi, Arnon Nagler
Publikováno v:
Biology of Blood and Marrow Transplantation. 22:277-283
Human recombinant granulocyte colony-stimulating factor (G-CSF), filgrastim (Neupogen; Amgen, Thousand Oaks, CA, USA), has been widely used for the mobilization of CD34(+) hematopoietic stem cells (HSC) from healthy donors. The experience with biosim
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d89eda9231691ccd79130c84efe3b93
https://doi.org/10.1016/j.bbmt.2015.08.033
https://doi.org/10.1016/j.bbmt.2015.08.033
Autor:
Katia Beider, David Naor, Nira Bloom, Avichai Shimoni, Olga Ostrovsky, Hanna Bitner, Valeria Voevoda, Evgenia Rosenberg, Simone Tal, Ivetta Danilesko, Arnon Nagler
Publikováno v:
Blood. 126:1889-1889
Polyclonal anti-human T-lymphocyte immunoglobulin(ATG) have been recently shown, in two randomized studies, to significantly reduce the incidence of graft versus host disease (GVHD) post allogeneic stem cell transplantation (HSCT) from both sibling a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fa22a12d701761e1b498ed669f2914c9
https://doi.org/10.1182/blood.v126.23.1889.1889
https://doi.org/10.1182/blood.v126.23.1889.1889
Autor:
Arnon Afek, Eliott Sigal, Lei Zhao, Nira Bloom, Aviv Shaish, Colin D. Funk, Hana Levkovitz, Tillmann Cyrus, Dror Harats, Jacob George
Publikováno v:
Circulation. 104(14)
Background Human 15-lipoxygenase (LO) and its murine analogue 12/15-LO are capable of directly oxidizing esterified fatty acids in lipoproteins and phospholipids. Because these oxidized products possess atherogenic properties, it was suggested that L
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d20cf877db37b58415882e5cd7d11e5
https://pubmed.ncbi.nlm.nih.gov/11581143
https://pubmed.ncbi.nlm.nih.gov/11581143
Autor:
Avichai Shimoni, Rina Sareli, Yulia Volchek, Nira Bloom-Varda, Ivetta Danylesko, Arnon Nagler, Ronit Yerushalmi, Noga Shem-Tov
Publikováno v:
Blood. 122:3275-3275
Introduction Human recombinant G-CSF Filgrastim (Neupogen) has been widely used for the mobilization of CD34+ hematopoietic stem cells (HSC) from healthy donors. The experience with biosimilar G-CSF agents is limited and the only publication, to our
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c93a4e96c6b0a9ef2d4f12bc118150a
https://doi.org/10.1182/blood.v122.21.3275.3275
https://doi.org/10.1182/blood.v122.21.3275.3275
Publikováno v:
Blood. 118:2011-2011
Abstract 2011 AlloSCT is the treatment of choice in advanced CML (>CP1) and in Ph+ ALL. However, the post transplant relapse rate is high and outcome is rather poor in this setting. Nilotinib (Tasigna, Novartis Pharmaceuticals) is a very effective, s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e490424d6ecb24126787dffefc147d32
https://doi.org/10.1182/blood.v118.21.2011.2011
https://doi.org/10.1182/blood.v118.21.2011.2011
Autor:
Arnon Nagler, Merav Leiba, Katia Beider, Elena Ribakovsky, Amnon Peled, Avichai Shimoni, Odit Gutwein, Nira Bloom
Publikováno v:
Blood. 116:2962-2962
Abstract 2962 Background: Multiple myeloma (MM) is characterized by clonal proliferation of malignant plasma cells (PCs) in the bone marrow (BM) compartment. Interaction of plasma cells with the BM stromal cells (BMSCs) is critical for homing, growth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bb7fb0a7481ffba5281c266edb20870c
https://doi.org/10.1182/blood.v116.21.2962.2962
https://doi.org/10.1182/blood.v116.21.2962.2962